Inozyme Pharma, Inc. (INZY)
   Jul 1, 2025 - INZY was delisted (reason: acquired by BMRN) 
4.000
 0.00 (0.00%)
   Inactive · Last trade price on Jun 30, 2025
Inozyme Pharma Employees
Inozyme Pharma had 67 employees as of December 31, 2024. The number of employees increased by 8 or 13.56% compared to the previous year.
Employees 
 67
Change (1Y) 
 8
Growth (1Y) 
 13.56%
Revenue / Employee 
 n/a
Profits / Employee 
 -$1,592,776
Market Cap 
259.66M
Employees Chart
Employees History
| Date | Employees | Change | Growth | 
|---|---|---|---|
| Dec 31, 2024 | 67 | 8 | 13.56% | 
| Dec 31, 2023 | 59 | 3 | 5.36% | 
| Dec 31, 2022 | 56 | 6 | 12.00% | 
| Dec 31, 2021 | 50 | 12 | 31.58% | 
| Dec 31, 2020 | 38 | - | - | 
INZY News
- 3 months ago - BioMarin: Acquisition Of Inozyme Brings Forth Late-Stage ERT BMN 401 - Seeking Alpha
 - 4 months ago - BioMarin Announces Completion of Acquisition of Inozyme - PRNewsWire
 - 4 months ago - Inozyme Pharma, Inc. Announces Postponement of 2025 Annual Meeting of Stockholders - GlobeNewsWire
 - 5 months ago - INOZYME PHARMA INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Inozyme Pharma, Inc. - INZY - Business Wire
 - 6 months ago - BioMarin Strengthens Enzyme Therapy Business with Acquisition of Inozyme Pharma - PRNewsWire
 - 6 months ago - Inozyme Pharma Reports First Quarter 2025 Financial Results and Provides Business Highlights - GlobeNewsWire
 - 7 months ago - Inozyme Pharma Announces JBMR Plus Publication Demonstrating Real-World Impact of ENPP1 Deficiency - GlobeNewsWire
 - 7 months ago - Inozyme Pharma to Participate in the 24th Annual Needham Virtual Healthcare Conference - GlobeNewsWire